A UCLA student is suing multiple California health care providers and hospitals for medical negligence, alleging she was ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...

SIGN UP for TheStreet’s FREE Daily newsletter 💰💸 With the growing popularity of weight loss drugs like Ozempic, Wegovyn, ...

Henrik Wulff, the man in charge of product supply at Novo Nordisk, just spent $11 billion to try to fill an ocean. Novo has ...

Hims & Hers faces regulatory hurdles but shows strong business growth. Find out why HIMS stock is a "Hold" despite setbacks ...

Vivani Medical (VANI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on December 20. Analyst Naz ...

GLP-1 drugs are remarkably effective at addressing obesity, cardiovascular, and metabolic conditions, but investigators ...

People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their ...

The marketing initiative touts the protein and fiber content, which appeals to consumers taking weight-loss medications such ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming ...